Jintai Academy of culture donated Linglan pestilence Qing Chinese patent medicine to Zhongbai Industrial Park Development Company

发布于: 2021-02-26 00:00

On February 26, 2020, Yan Gang, general manager of Zhongbai Industrial Park Development Company, met with CAI Chuanqing, President of Jintai Academy of Arts. After the meeting, Cai Chuanqing donated a batch of linglanqing anti epidemic Chinese patent medicine to Zhongbai Industrial Park Development Company.



On behalf of the development company, general manager Yan Gang thanked president Cai Chuanqing for donating Chinese patent medicine, and said that since 2021, Jintai Academy of culture has actively participated in and promoted the relevant work of traditional Chinese medicine industry settled in Zhongbai Industrial Park, and has made good progress and achievements. The development company will continue to support and promote the traditional Chinese medicine enterprises driven by Jintai Academy of culture to settle in the park.



Recommended articles

  • 2021-11-18
    In the past eight years, the Belt and Road initiative has gone from initiative to action, from freehand brushwork to fine brushwork. Guided by General Secretary Xi Jinping, the Initiative has been guided by extensive consultation, joint contribution and shared benefits.
  • 2021-11-11
      The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released   Zhou Xingting   Yao jian   "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.     The world's first effective Chinese patent medicine for COVID-19 treatment   Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia    On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
  • 2021-11-10
      On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.   China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony     Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...